Compare Etsy Inc (ETSY) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Globus Medical Inc. Class A Common Stock — how do they compare? Etsy Inc trades at $82.96 (market cap $7.28B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Globus Medical Inc. Class A Common Stock is the larger of the two by market cap, and Etsy Inc is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| ETSY | GMED | |
|---|---|---|
Market Cap | $7.28B | $10.25B |
Volume | 2,112,607 | 1,108,124 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $96.82 |
52-Week Low | $44.05 | $58.33 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $9.23B | $9.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY is trading at $82.93, up 7.8% with strong momentum following three consecutive quarterly earnings beats. The stock shows bullish technical signals with positive moving averages and trades near analyst consensus targets. Recent news highlights AI integration initiatives and strategic partnerships, while financials show solid revenue growth but declining net margins from 11.19% in 2023 to 5.65% in 2025.
Outlook remains cautiously optimistic with 53% analyst buy ratings and $85.94 consensus target, though high P/B ratio and negative equity raise valuation concerns. Key risks include margin compression and competitive e-commerce pressures, while institutional accumulation and AI-driven personalization initiatives provide growth catalysts.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
